Another day, another high-level departure from FDA: This time, it's head of generic drugs

Article Highlights

  • Another day, and we have another senior level departure from the Food and Drug Administration

    Tweet This

  • The abrupt resignation of Dr. Greg Geba of the Office of Generic Drugs is part of a worrying spate of high-level departures inside the FDA

    Tweet This

  • The departure of FDA officials has the potential to create a real brain drain should the trend persist

    Tweet This

Another day, and we have another senior level departure from the Food and Drug Administration.

The memo below — circulated this afternoon inside FDA — announced the departure of the head of the drug center’s Office of Generic Drugs, Dr. Greg Geba. It’s noteworthy that this new chief had only been in his slot for less than a year.

His abrupt resignation is part of a worrying spate of high-level departures inside the drug center that, taken together, have the potential to create a real brain drain should the trend persist. Filling these high-level positions is no easy feat, and Geba had been recruited from outside FDA, from a position as deputy chief medical officer at Sanofi.

For FDA, recruiting external candidates into senior roles can be much more difficult, and take more time, than selecting internal applicants. For these and other reasons, FDA is often guilty of promoting too much from within; a habit that has certain advantages (internal hires know the agency’s unique traditions and precedents) but also drawbacks (promoting only from within can create an insular culture and deny the agency new perspectives). So when a high-level external recruit leaves after such a short period of time, it could make the agency more reluctant to take a chance on external hires down the road.

From: CDER Center Director
Sent: Wednesday, March 13, 2013 02:32 PM
To: FDA-CDER-wide
Subject: Changes in CDER’s Office of Generic Drugs
CDER Staff:

I would like to make you aware of a change in the Office of Generic Drugs’ (OGD) leadership.

Dr. Greg Geba, OGD director, has informed me that he will resign from his position on March 15. With the pending realignment of OGD’s CMC functions into the new Office of Pharmaceutical Quality (OPQ), which Dr. Geba fully supports as part of the quality evolution in CDER, he nonetheless saw this movement as creating challenges for implementing his original and full vision for OGD’s remit. Additionally, it put into new perspective considerations for him relocating his family to the Washington, D.C. area.

Dr. Geba came to CDER during a busy time and has led OGD’s work to improve efficiencies in the generic drug review process — significantly reducing the backlog of pending ANDAs, preparing for the hiring of new staff, and successfully guiding OGD in implementing the Generic Drug User Fee Act (GDUFA), as well as overseeing OGD-related organizational changes to stand up the new OPQ.

Please join me in thanking Dr. Geba for his significant contributions and wishing him well.

In the interim, I will serve as the acting OGD director while we initiate a nationwide search for our next OGD director.

Janet Woodcock

 

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Scott
Gottlieb

What's new on AEI

Defeating ISIS: AEI experts weigh-in before the president’s address on Wednesday
image Degrading, defeating, and destroying the Islamic State
image Wealth Building Home Loan: Building wealth through homeownership and retirement savings
image The $3 iPhone
AEI on Facebook
Events Calendar
  • 15
    MON
  • 16
    TUE
  • 17
    WED
  • 18
    THU
  • 19
    FRI
Tuesday, September 16, 2014 | 5:00 p.m. – 6:00 p.m.
The Constitution as political theory

Please join us for the third-annual Walter Berns Constitution Day Lecture as James Ceasar, Harry F. Byrd Professor of Politics at the University of Virginia, explores some of the Constitution’s most significant contributions to political theory, focusing on themes that have been largely unexamined in current scholarship.

Wednesday, September 17, 2014 | 8:10 a.m. – Thursday, September 18, 2014 | 1:30 p.m.
Third international conference on housing risk: New risk measures and their applications

We invite you to join us for this year’s international conference on housing risk — cosponsored by the Collateral Risk Network and AEI International Center on Housing Risk — which will focus on new mortgage and collateral risk measures and their applications.

Thursday, September 18, 2014 | 2:15 p.m. – 3:00 p.m.
Speaker of the House John Boehner on resetting America’s economic foundation

Please join us as Speaker John Boehner (R-OH) delivers his five-point policy vision to reset America’s economy.

Friday, September 19, 2014 | 9:15 a.m. – 11:00 a.m.
Reforming Medicare: What does the public think?

Please join us as a panel of distinguished experts explore the implications of the report and the consumer role in shaping the future of Medicare.

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.